X-67951456-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000680612.1(OPHN1):​c.1687-1871C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.436 in 109,532 control chromosomes in the GnomAD database, including 8,418 homozygotes. There are 13,390 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 8418 hom., 13390 hem., cov: 22)

Consequence

OPHN1
ENST00000680612.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0700

Publications

3 publications found
Variant links:
Genes affected
OPHN1 (HGNC:8148): (oligophrenin 1) This gene encodes a Rho-GTPase-activating protein that promotes GTP hydrolysis of Rho subfamily members. Rho proteins are important mediators of intracellular signal transduction, which affects cell migration and cell morphogenesis. Mutations in this gene are responsible for OPHN1-related X-linked cognitive disability with cerebellar hypoplasia and distinctive facial dysmorhphism. [provided by RefSeq, Jul 2008]
OPHN1 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability-cerebellar hypoplasia syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.649 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000680612.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
OPHN1
ENST00000680612.1
c.1687-1871C>A
intron
N/AENSP00000505365.1

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
47715
AN:
109477
Hom.:
8405
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.656
Gnomad AMI
AF:
0.186
Gnomad AMR
AF:
0.381
Gnomad ASJ
AF:
0.318
Gnomad EAS
AF:
0.317
Gnomad SAS
AF:
0.331
Gnomad FIN
AF:
0.321
Gnomad MID
AF:
0.442
Gnomad NFE
AF:
0.355
Gnomad OTH
AF:
0.444
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.436
AC:
47773
AN:
109532
Hom.:
8418
Cov.:
22
AF XY:
0.421
AC XY:
13390
AN XY:
31822
show subpopulations
African (AFR)
AF:
0.656
AC:
19724
AN:
30059
American (AMR)
AF:
0.380
AC:
3889
AN:
10224
Ashkenazi Jewish (ASJ)
AF:
0.318
AC:
832
AN:
2620
East Asian (EAS)
AF:
0.316
AC:
1076
AN:
3400
South Asian (SAS)
AF:
0.330
AC:
849
AN:
2569
European-Finnish (FIN)
AF:
0.321
AC:
1836
AN:
5718
Middle Eastern (MID)
AF:
0.462
AC:
97
AN:
210
European-Non Finnish (NFE)
AF:
0.355
AC:
18673
AN:
52572
Other (OTH)
AF:
0.451
AC:
673
AN:
1493
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
904
1807
2711
3614
4518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
444
888
1332
1776
2220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.353
Hom.:
9452
Bravo
AF:
0.450

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.45
DANN
Benign
0.37
PhyloP100
-0.070

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2363785; hg19: chrX-67171298; API